Selected research
Industry Research
Immunology-Oncology Elisa Kits Industry Research Report 2026
Market perspective
The global Immunology-Oncology Elisa Kits market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Immunology-Oncology Elisa Kits is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Immunology-Oncology Elisa Kits is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Immunology-Oncology Elisa Kits is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Immunology-Oncology Elisa Kits include Thermo Fisher Scientific, MilliporeSigma (Merck KGaA), RayBiotech Life, Inc., Enzo Life Sciences, ELISAGEN Biotech, Creative Diagnostics, Bio-Techne Corporation (R&D Systems), BioLegend (part of PerkinElmer) and BD Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Immunology-Oncology Elisa Kits market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Immunology-Oncology Elisa Kits Market by Company
Thermo Fisher Scientific
MilliporeSigma (Merck KGaA)
RayBiotech Life, Inc.
Enzo Life Sciences
ELISAGEN Biotech
Creative Diagnostics
Bio-Techne Corporation (R&D Systems)
BioLegend (part of PerkinElmer)
BD Biosciences
Abcam
Immunology-Oncology Elisa Kits Segment by Type
Direct ELISA Kit
Indirect ELISA Kit
Immunology-Oncology Elisa Kits Segment by Application
Cancer Diagnosis
Pharmaceutical Industry
Other
Immunology-Oncology Elisa Kits Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunology-Oncology Elisa Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immunology-Oncology Elisa Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunology-Oncology Elisa Kits.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Immunology-Oncology Elisa Kits manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Immunology-Oncology Elisa Kits by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Immunology-Oncology Elisa Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Direct ELISA Kit
- Indirect ELISA Kit
Applications
- Cancer Diagnosis
- Pharmaceutical Industry
- Other
Companies covered
- Thermo Fisher Scientific
- MilliporeSigma (Merck KGaA)
- RayBiotech Life, Inc.
- Enzo Life Sciences
- ELISAGEN Biotech
- Creative Diagnostics
- Bio-Techne Corporation (R&D Systems)
- BioLegend (part of PerkinElmer)
- BD Biosciences
- Abcam
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Immunology-Oncology Elisa Kits Market Size (2021-2032)
- 2.2.2 Global Immunology-Oncology Elisa Kits Sales (2021-2032)
- 2.2.3 Global Immunology-Oncology Elisa Kits Market Average Price (2021-2032)
- 2.3 Immunology-Oncology Elisa Kits by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Direct ELISA Kit
- 2.3.3 Indirect ELISA Kit
- 2.4 Immunology-Oncology Elisa Kits by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cancer Diagnosis
- 2.4.3 Pharmaceutical Industry
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Immunology-Oncology Elisa Kits Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Immunology-Oncology Elisa Kits Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Immunology-Oncology Elisa Kits Revenue of Manufacturers (2021-2026)
- 3.4 Global Immunology-Oncology Elisa Kits Average Price by Manufacturers (2021-2026)
- 3.5 Global Immunology-Oncology Elisa Kits Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Immunology-Oncology Elisa Kits, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Immunology-Oncology Elisa Kits, Product Type & Application
- 3.8 Global Manufacturers of Immunology-Oncology Elisa Kits, Established Date
- 3.9 Global Immunology-Oncology Elisa Kits Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher Scientific
- 4.1.1 Thermo Fisher Scientific Company Information
- 4.1.2 Thermo Fisher Scientific Business Overview
- 4.1.3 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Product Portfolio
- 4.1.5 Thermo Fisher Scientific Recent Developments
- 4.2 MilliporeSigma (Merck KGaA)
- 4.2.1 MilliporeSigma (Merck KGaA) Company Information
- 4.2.2 MilliporeSigma (Merck KGaA) Business Overview
- 4.2.3 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Product Portfolio
- 4.2.5 MilliporeSigma (Merck KGaA) Recent Developments
- 4.3 RayBiotech Life, Inc.
- 4.3.1 RayBiotech Life, Inc. Company Information
- 4.3.2 RayBiotech Life, Inc. Business Overview
- 4.3.3 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Product Portfolio
- 4.3.5 RayBiotech Life, Inc. Recent Developments
- 4.4 Enzo Life Sciences
- 4.4.1 Enzo Life Sciences Company Information
- 4.4.2 Enzo Life Sciences Business Overview
- 4.4.3 Enzo Life Sciences Immunology-Oncology Elisa Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Enzo Life Sciences Immunology-Oncology Elisa Kits Product Portfolio
- 4.4.5 Enzo Life Sciences Recent Developments
- 4.5 ELISAGEN Biotech
- 4.5.1 ELISAGEN Biotech Company Information
- 4.5.2 ELISAGEN Biotech Business Overview
- 4.5.3 ELISAGEN Biotech Immunology-Oncology Elisa Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 ELISAGEN Biotech Immunology-Oncology Elisa Kits Product Portfolio
- 4.5.5 ELISAGEN Biotech Recent Developments
- 4.6 Creative Diagnostics
- 4.6.1 Creative Diagnostics Company Information
- 4.6.2 Creative Diagnostics Business Overview
- 4.6.3 Creative Diagnostics Immunology-Oncology Elisa Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Creative Diagnostics Immunology-Oncology Elisa Kits Product Portfolio
- 4.6.5 Creative Diagnostics Recent Developments
- 4.7 Bio-Techne Corporation (R&D Systems)
- 4.7.1 Bio-Techne Corporation (R&D Systems) Company Information
- 4.7.2 Bio-Techne Corporation (R&D Systems) Business Overview
- 4.7.3 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Product Portfolio
- 4.7.5 Bio-Techne Corporation (R&D Systems) Recent Developments
- 4.8 BioLegend (part of PerkinElmer)
- 4.8.1 BioLegend (part of PerkinElmer) Company Information
- 4.8.2 BioLegend (part of PerkinElmer) Business Overview
- 4.8.3 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Product Portfolio
- 4.8.5 BioLegend (part of PerkinElmer) Recent Developments
- 4.9 BD Biosciences
- 4.9.1 BD Biosciences Company Information
- 4.9.2 BD Biosciences Business Overview
- 4.9.3 BD Biosciences Immunology-Oncology Elisa Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 BD Biosciences Immunology-Oncology Elisa Kits Product Portfolio
- 4.9.5 BD Biosciences Recent Developments
- 4.10 Abcam
- 4.10.1 Abcam Company Information
- 4.10.2 Abcam Business Overview
- 4.10.3 Abcam Immunology-Oncology Elisa Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Abcam Immunology-Oncology Elisa Kits Product Portfolio
- 4.10.5 Abcam Recent Developments
5 Global Immunology-Oncology Elisa Kits Market Scenario by Region
- 5.1 Global Immunology-Oncology Elisa Kits Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Immunology-Oncology Elisa Kits Sales by Region: 2021-2032
- 5.2.1 Global Immunology-Oncology Elisa Kits Sales by Region: 2021-2026
- 5.2.2 Global Immunology-Oncology Elisa Kits Sales by Region: 2027-2032
- 5.3 Global Immunology-Oncology Elisa Kits Revenue by Region: 2021-2032
- 5.3.1 Global Immunology-Oncology Elisa Kits Revenue by Region: 2021-2026
- 5.3.2 Global Immunology-Oncology Elisa Kits Revenue by Region: 2027-2032
- 5.4 North America Immunology-Oncology Elisa Kits Market Facts & Figures by Country
- 5.4.1 North America Immunology-Oncology Elisa Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Immunology-Oncology Elisa Kits Sales by Country (2021-2032)
- 5.4.3 North America Immunology-Oncology Elisa Kits Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Immunology-Oncology Elisa Kits Market Facts & Figures by Country
- 5.5.1 Europe Immunology-Oncology Elisa Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Immunology-Oncology Elisa Kits Sales by Country (2021-2032)
- 5.5.3 Europe Immunology-Oncology Elisa Kits Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Immunology-Oncology Elisa Kits Market Facts & Figures by Country
- 5.6.1 Asia Pacific Immunology-Oncology Elisa Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Immunology-Oncology Elisa Kits Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Immunology-Oncology Elisa Kits Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Immunology-Oncology Elisa Kits Market Facts & Figures by Country
- 5.7.1 South America Immunology-Oncology Elisa Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Immunology-Oncology Elisa Kits Sales by Country (2021-2032)
- 5.7.3 South America Immunology-Oncology Elisa Kits Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Immunology-Oncology Elisa Kits Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Immunology-Oncology Elisa Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Immunology-Oncology Elisa Kits Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Immunology-Oncology Elisa Kits Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Immunology-Oncology Elisa Kits Sales by Type (2021-2032)
- 6.1.1 Global Immunology-Oncology Elisa Kits Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2021-2032)
- 6.2 Global Immunology-Oncology Elisa Kits Revenue by Type (2021-2032)
- 6.2.1 Global Immunology-Oncology Elisa Kits Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2021-2032)
- 6.3 Global Immunology-Oncology Elisa Kits Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Immunology-Oncology Elisa Kits Sales by Application (2021-2032)
- 7.1.1 Global Immunology-Oncology Elisa Kits Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2021-2032)
- 7.2 Global Immunology-Oncology Elisa Kits Revenue by Application (2021-2032)
- 7.2.1 Global Immunology-Oncology Elisa Kits Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2021-2032)
- 7.3 Global Immunology-Oncology Elisa Kits Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Immunology-Oncology Elisa Kits Value Chain Analysis
- 8.1.1 Immunology-Oncology Elisa Kits Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Immunology-Oncology Elisa Kits Production Mode & Process
- 8.2 Immunology-Oncology Elisa Kits Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Immunology-Oncology Elisa Kits Distributors
- 8.2.3 Immunology-Oncology Elisa Kits Customers
9 Global Immunology-Oncology Elisa Kits Analyzing Market Dynamics
- 9.1 Immunology-Oncology Elisa Kits Industry Trends
- 9.2 Immunology-Oncology Elisa Kits Industry Drivers
- 9.3 Immunology-Oncology Elisa Kits Industry Opportunities and Challenges
- 9.4 Immunology-Oncology Elisa Kits Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst